TRIM72 Antibody
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


TRIM72 Antibody
Description:
Enables identical protein binding activity. Predicted to be involved in several processes, including cellular protein metabolic process; plasma membrane repair; and protein homooligomerization. Predicted to act upstream of or within negative regulation of insulin receptor signaling pathway; negative regulation of insulin-like growth factor receptor signaling pathway; and negative regulation of myotube differentiation. Predicted to be located in cytoplasmic vesicle membrane. Predicted to be active in cytoplasm and sarcolemma.Specifications:
Western blot: 0.5-1 µg/mL, Immunohistochemistry (FFPE) : 2-5 µg/mL, Immunofluorescence: 5 µg/mL, Flow cytometry: 1-3ug/million cells, Direct ELISA: 0.1-0.5 µg/mLUniProt:
Q6ZMU5Host:
RabbitReactivity:
Human, Mouse, RatImmunogen:
E. coli-derived recombinant human protein (amino acids E28-A477) was used as the immunogen for the TRIM72 antibody.Clonality:
PolyclonalIsotype:
IgGApplications:
WB, IHC-P, IF, FACS, Direct ELISAPurity:
Antigen affinity purifiedFormat:
Antigen affinity purifiedBuffer:
Lyophilized from 1X PBS with 2% TrehaloseReconstitution:
After reconstitution, the TRIM72 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.Limitations:
This TRIM72 antibody is available for research use only.Storage Conditions:
After reconstitution, the TRIM72 antibody can be stored for up to one month at 4°C. For long-term, aliquot and store at -20°C. Avoid repeated freezing and thawing.Formulation:
0.5 mg/mL if reconstituted with 0.2ml sterile DI waterApplications Notes:
Optimal dilution of the TRIM72 antibody should be determined by the researcher.CAS Number:
9007-83-4Location:
Cell membraneImage Legend:
Immunofluorescent staining of FFPE human skeletal muscle tissue with TRIM72 antibody (red) and DAPI nuclear stain (blue) . HIER: steam section in pH8 EDTA buffer for 20 min.
